a public good project by the
Synthesis
Company
of California

© 2026

Chih‐Hung Lee | doi.page

0 works0 citations0 h-index

Chih‐Hung Lee

National Sun Yat-sen University(TW)Chang Gung University(TW)Kaohsiung Chang Gung Memorial Hospital(TW)

Publications by Year

Research Areas

Dermatology and Skin Diseases, Allergic Rhinitis and Sensitization, Psoriasis: Treatment and Pathogenesis, Arsenic contamination and mitigation, Urticaria and Related Conditions

Most-Cited Works

→ A-317491, a novel potent and selective non-nucleotide antagonist of P2X ₃ and P2X _2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat(2002)459 cited
→ Molecular Mechanisms of UV-Induced Apoptosis and Its Effects on Skin Residential Cells: The Implication in UV-Based Phototherapy(2013)255 cited
→ A-425619 [1-Isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a Novel Transient Receptor Potential Type V1 Receptor Antagonist, Relieves Pathophysiological Pain Associated with Inflammation and Tissue Injury in Rats(2005)254 cited
→ Effects of A‐317491, a novel and selective P2X₃/P2X_2/3 receptor antagonist, on neuropathic, inflammatory and chemogenic nociception following intrathecal and intraplantar administration(2003)177 cited
→ Development of a light‐weight deep learning model for cloud applications and remote diagnosis of skin cancers(2020)113 cited

→ Arsenic-Induced Carcinogenesis and Immune Dysregulation(2019)

113 cited

→ A-425619 [1-Isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a Novel and Selective Transient Receptor Potential Type V1 Receptor Antagonist, Blocks Channel Activation by Vanilloids, Heat, and Acid(2005)110 cited

→ ABT-702 (4-Amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a Novel Orally Effective Adenosine Kinase Inhibitor with Analgesic and Anti-Inflammatory Properties. II. In Vivo Characterization in the Rat(2000)104 cited

→ ITPKC Single Nucleotide Polymorphism Associated with the Kawasaki Disease in a Taiwanese Population(2011)97 cited

→ ABT-702 (4-Amino-5-(3-bromophenyl)-7-(6-morpholinopyridin-3-yl)pyrido[2,3-d]pyrimidine), a Novel Orally Effective Adenosine Kinase Inhibitor with Analgesic and Anti-Inflammatory Properties: I. In Vitro Characterization and Acute Antinociceptive Effects in the Mouse(2000)91 cited